Peter Goldschmidt

Member of the Board (Vice Chair). AAM is the generics and biosimilar industry association in the U.S..

Peter GOLDSCHMIDT, Professor (Full) | Cited by 120 | of The University of Western Australia, Perth (UWA) | Read 21 publications | Contact Peter GOLDSCHMIDT.

Peter Goldschmidt is CEO of STADA Arzneimittel AG. He strongly pursuits the STADA vision, to be the partner of choice in generics, specialty medicines and

Peter Goldschmidt, Professor, Information Management, The University of Western Australia. Verified email at uwa.edu.au - Homepage

Peter Goldschmidt has been CEO of STADA Arzneimittel AG since 1 September 2018; following the PE takeover by Bain Capital and Cinven.

Peter Goldschmidt was the Head of Institutional Relations at EIPA. Until August 2021, Peter has been Director of EIPA Luxembourg, the European Centre for

Experience · Professor. The Uni Western Australia · Professor. The Unveristy of Western Australia. Aug 1982 - Present 43 years 2 months. Perth Western Australia

Peter Goldschmidt has 28 years' experience and success in the pharmaceutical industry with Novartis Pharma. He worked in OTC, Generics and the innovative Pharma.